The FDA investigation into AC and GLP-1 RA drugs reported: The median age for people who developed AC was 55 years old Of the people who developed AC, 53% were female After starting the drug, 47% of patients developed AC within 90 days Cholelithiasis, or gallstones, was also added to the approval label
ACHIEVE-1 was a 40-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of orforglipron 3 mg, 12 mg, and 36 mg vs
Topical palmitoyl pentapeptide provides improvement in photoaged mammalian facial skin
The clinic is very professional and Dr
Dietary interventions for autism spectrum disorder: A meta-analysis
If your family physician doesnt have any answers, we encourage you to make an appointment with a hematologist (a blood specialist)